Scribe Therapeutics is a privately held company tracked for investment-relevant business and technology developments.
This slot renders the company's funding history: dates, rounds, amounts, valuations and lead investors once populated in data/funding-rounds.json.
epI-editing alters protein production without permanent DNA changes, enabling safe, repeatable treatment for common diseases like high LDL cholesterol; Phase 1 underway and IPO proceeds will advance clinical deployment.